NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
- PMID: 28596256
- DOI: 10.6004/jnccn.2017.0101
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. Recommendations are also provided for occult primary of the head and neck (H&N), and separate algorithms have been developed by the panel for very advanced H&N cancers. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding the increase in human papillomavirus-associated oropharyngeal cancer and the availability of immunotherapy agents for treatment of patients with recurrent or metastatic H&N cancer.
Copyright © 2017 by the National Comprehensive Cancer Network.
Similar articles
-
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026. J Natl Compr Canc Netw. 2018. PMID: 29752322
-
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.J Natl Compr Canc Netw. 2022 Mar;20(3):224-234. doi: 10.6004/jnccn.2022.0016. J Natl Compr Canc Netw. 2022. PMID: 35276673
-
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.J Natl Compr Canc Netw. 2025 Feb;23(2):2-11. doi: 10.6004/jnccn.2025.0007. J Natl Compr Canc Netw. 2025. PMID: 39938471
-
Updated National Comprehensive Cancer Network guidelines for treatment of head and neck cancers 2010-2017.Otolaryngol Pol. 2017 Dec 30;71(6):1-6. doi: 10.5604/01.3001.0010.7193. Otolaryngol Pol. 2017. PMID: 29327681 Review.
-
AHNS Series - Do you know your guidelines?: Assessment and management of malnutrition in patients with head and neck cancer: Review of the NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines).Head Neck. 2019 Mar;41(3):577-583. doi: 10.1002/hed.24866. Epub 2018 Dec 31. Head Neck. 2019. PMID: 30597657 Review.
Cited by
-
lncRNA lnc-POP1-1 upregulated by VN1R5 promotes cisplatin resistance in head and neck squamous cell carcinoma through interaction with MCM5.Mol Ther. 2022 Jan 5;30(1):448-467. doi: 10.1016/j.ymthe.2021.06.006. Epub 2021 Jun 8. Mol Ther. 2022. PMID: 34111560 Free PMC article.
-
A meta-analysis of cisplatin-based concurrent chemoradiotherapy with or without cetuximab for locoregionally advanced nasopharyngeal carcinoma.Medicine (Baltimore). 2019 Oct;98(42):e17486. doi: 10.1097/MD.0000000000017486. Medicine (Baltimore). 2019. PMID: 31626102 Free PMC article.
-
Cervical lymphadenopathy: can the histogram analysis of apparent diffusion coefficient help to differentiate between lymphoma and squamous cell carcinoma in patients with unknown clinical primary tumor?Radiol Med. 2019 Jan;124(1):19-26. doi: 10.1007/s11547-018-0940-1. Epub 2018 Sep 8. Radiol Med. 2019. PMID: 30196522
-
Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma Patients.Front Oncol. 2020 Mar 20;10:378. doi: 10.3389/fonc.2020.00378. eCollection 2020. Front Oncol. 2020. PMID: 32266152 Free PMC article.
-
Radiotherapy Controversies and Prospective in Head and Neck Cancer: A Literature-Based Critical Review.Neoplasia. 2018 Mar;20(3):227-232. doi: 10.1016/j.neo.2018.01.002. Epub 2018 Feb 12. Neoplasia. 2018. PMID: 29448084 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical